Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1614 1628
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19417018 | SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY | Non-Final OA | Allergan, Inc. |
| 18317725 | METHODS OF TREATING HEAVY MENSTRUAL BLEEDING | Non-Final OA | AbbVie Inc. |
| 17325900 | METHODS OF TREATING HEAVY MENSTRUAL BLEEDING | Non-Final OA | AbbVie Inc. |
| 17242755 | COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-INTENSIVE CARE COGNITIVE DYSFUNCTION AND COGNITIVE DYSFUNCTION RESULTING FROM RESPIRATORY DISTRESS | Non-Final OA | Abrexa Pharmaceuticals, Inc. |
| 18853643 | Indolium Compounds for Treating Cancer | Non-Final OA | Emory University |
| 18294823 | METHODS OF TREATING MIGRAINE WITH MNK INHIBITORS | Non-Final OA | Board of Regents, The University of Texas System |
| 17329742 | COSMETIC COMPOSITION COMPRISING VITAMIN C | Non-Final OA | L'OREAL |
| 17773775 | METABOLIC REPROGRAMMING OF IMMUNE CELLS TO ENHANCE THE EFFICACY OF PROPHYLACTIC AND THERAPEUTIC VACCINES | Final Rejection | Sanford Burnham Prebys Medical Discovery Institute |
| 18456718 | IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | Final Rejection | Arvinas Operations, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy